Manish R. Patel

4.0k citations

94 papers · 1.7k indexed · h-index 23

Oncology top 5%
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 15
- Lung Cancer Research Studies 10
Pathology and Forensic Medicine top 5%
Immunology top 10%
Genetics top 10%
- Virus-based gene therapy research 19
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 19
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 8
Animal Science and Zoology
- Animal Virus Infections Studies 7
Biotechnology
- Cancer Research and Treatments 7

Co-authors: Robert A. Kratzke Blake A. Jacobson Simcha Pollack John F. Aloia Mageda Mikhail Melissa Li‐Ng James K. Yeh Sanjiv S. Gambhir
Cited by: Oncology Pathology and Forensic Medicine Immunology
Journals: Annals of Oncology (13 papers)Journal of Clinical Oncology (9 papers)Journal of Thoracic Oncology (8 papers)
Partner nations: United States Japan Italy

In The Last Decade

Manish R. Patel

88 papers receiving 1.7k citations

Peers

Countries citing papers authored by Manish R. Patel

Since Specialization

Citations

This map shows the geographic impact of Manish R. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish R. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish R. Patel more than expected).

Fields of papers citing papers by Manish R. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish R. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish R. Patel. The network helps show where Manish R. Patel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manish R. Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manish R. Patel Line = papers co-authored together Manish R. Patel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of anti-cancer medicines in the current era Cancer Treatment and Research Communications ·Bradley J. Monk,Manish R. Patel,Sarper Toker,Vivek Subbiah,Lucio Gordan	2025	0
2	Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy Karan Ramakrishna,Manish R. Patel,Naomi Fujioka,Robert A. Kratzke,Amit Kulkarni	2024	1
3	Abstract PO-009: AC676 a BTK Chimeric Degrader: Phase 1 study in patients with B-cell Malignancies Blood Cancer Discovery ·Manish R. Patel,Michael Tees,Farrukh T. Awan,Nadia Khan,浩徳渕,Azhari Shamsudeen,Su Young Kim,Jennifer A. Woyach	2024	3
4	1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Annals of Oncology ·Adis Tassanarong,Manish R. Patel,Т. А. Замощина,Tsonchumi Odyuo,A.M.-T. Kim,Jessica E. Hawley,S. Srinivas,Ben Clifford,Vivek Narayan,Karie Runcie,Hamid Emamekhoo,Lipi Rina,刘少民,Amber L. Wells,Raju Kandimalla,Satyendra Suryawanshi,Jiao Wu,Vivek Arora,Michael Pourdehnad,Amy J. Armstrong	2024	2
5	616MO Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors Annals of Oncology ·June Wyer,Manish R. Patel,Patricia Whitcomb Coupeville,Adrian G. Sacher,Mrio Lima de Alencastro Graa,Anna Santoro,حسين الجيار,Luis Paz‐Ares,Juan Camilo Castellanos Rivera,P D Wittman,Vitor Pereira Salles,Rafał Dziadziuszko,Sae‐Hoon Kim,Seung Woo Han,李文鳳,Patricia LoRusso,Rasha Cosman,Julie Chang,Tomi Jun,R. Bermúdez-Peinado	2024	1
6	Composition and Chemistry of the Martian Atmosphere as Observed by Mars Express and ExoMars Trace Gas Orbiter Space Science Reviews ·Ann Carine Vandaele,Shohei Aoki,Sophie Bauduin,Frank Daerden,Anna Fedorova,M. Giuranna,Oleg Korablev,Franck Lefèvre,Anni Määttänen,Franck Montmessin,Manish R. Patel,M. D. Smith,Loïc Trompet,S. Viscardy,Yannick Willame,Irma Riquelme	2024	6
7	Engineered Cellular Therapies for the Treatment of Thoracic Cancers Cancers ·Spencer M Erickson,Benjamin M. Manning,Akhilesh Kumar,Manish R. Patel	2024	2
8	Success of Checkpoint Blockade Paves the Way for Novel Immune Therapy in Malignant Pleural Mesothelioma Cancers ·Alan Wachtman,C. B. Edward,Manish R. Patel	2023	7
9	MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy Journal of Thoracic Oncology ·Kai He,David Berz,Shirish M. Gadgeel,Wade T. Iams,Débora S. Bruno,Collin M. Blakely,Alexander I. Spira,Manish R. Patel,David Waterhouse,Donald Richards,Anthony Pham,Robert M. Jotte,David S. Hong,Edward B. Garon,Anne M. Traynor,Peter Olson,BABU LAL,Xiaohong Yan,Ronald Shazer,Ticiana Leal	2023	20
10	43P MRTX-500: Phase II trial of sitravatinib (sitra) + nivolumab (nivo) in patients (pts) with non-squamous (NSQ) non-small cell lung cancer (NSCLC) progressing on or after prior checkpoint inhibitor (CPI) therapy Annals of Oncology ·Ticiana Leal,David Berz,Igor I. Rybkin,Wade T. Iams,Débora S. Bruno,Collin M. Blakely,Alexander I. Spira,Manish R. Patel,David Waterhouse,Donald Richards,Anthony Pham,Robert M. Jotte,A. Meunier,David S. Hong,Ronald Shazer,Xiaohong Yan,Aurora de la Vega de Deza,Kai He	2022	13
11	Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer Clinical Medicine Insights Oncology ·डाॅ उर्मिला वर्मा,C. H. Li,Amit Kulkarni,Manoj Kumar,Ryan Shanley,Beibei Xu,Stephan Ernst,Manish R. Patel	2021	16
12	Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types ESMO Open ·Amit Kulkarni,Maryam Ebadi,डाॅ उर्मिला वर्मा,Mohamad Aghaie Meybodi,Alaa M. Ali,Todd E. DeFor,Ryan Shanley,Daniel Weisdorf,Charles J. Ryan,Sumithira Vasu,Armin Rashidi,Manish R. Patel	2020	26
13	O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001) Annals of Oncology ·Manish R. Patel,Salvatore Siena,George D. Demetri,Robert C. Doebele,Younbyoung Chae,Paul Conkling,Ignacio Garrido‐Laguna,Federico Longo,Christian Rolfo,Darren Sigal,Alexander Drilon,佐土海伊橋,Kōichi Goto,Lyudmila Bazhenova,Sara Lonardi,Fortunato Ciardiello,Xiaoxiao Huang,Stuart Osborne,Gabriela Villanueva Caceres,Filippo de Braud	2020	13
14	1288P Efficacy of entrectinib in patients with NTRK or ROS1 fusion-positive NSCLC with CNS metastases at baseline Annals of Oncology ·Rafał Dziadziuszko,Salvatore Siena,Daniel S.W. Tan,Byoung Chul Cho,M-J. Ahn,Kōichi Goto,Pilar Garrido,Anna F. Farago,Herbert H. Loong,Diégo Tosi,Thomas John,Juergen Wolf,Issam Fakir,Stephen V. Liu,Manish R. Patel,Alexander Drilon,Bethany Pitcher,Brian Simmons,Robert C. Doebele	2020	5
15	1287P Efficacy and safety of entrectinib in locally advanced/metastatic ROS1 fusion-positive NSCLC: An updated integrated analysis Annals of Oncology ·Matthew Krebs,Filippo de Braud,Salvatore Siena,Alexander Drilon,Robert C. Doebele,Manish R. Patel,Byoung Chul Cho,Stephen V. Liu,M-J. Ahn,Issam Fakir,Anna F. Farago,C-C. Lin,Christos S. Karapetis,Yu‐Chuan Li,Fabrice Barlési,Brian Simmons,Bethany Pitcher,Rafał Dziadziuszko	2020	3
16	A37 N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist Journal of Thoracic Oncology ·John Wrangle,Vamsidhar Velcheti,Manish R. Patel,Roberta Boscolo Sesilla,Michael S Krochmal,Cecil H. Coggins,Steven H. Kwok,William L. Redmond,S. Moracchini,Imche Fourie,Mark P. Rubinstein	2020	1
17	Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer Translational Oncology ·Manish R. Patel,Blake A. Jacobson,Yan Ji,Robert P. Hebbel,Robert A. Kratzke	2020	13
18	A review of avelumab in locally advanced and metastatic bladder cancer Therapeutic Advances in Urology ·Arpit Rao,Manish R. Patel	2019	17
19	Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor Annals of Oncology ·Ruth H. U. Borges,YU Xiao-guang,Michael Bailey,Alexa B. Schrock,Samuel J. Klempner,Garrett M. Frampton,David Fabrizio,S.‐H.I. Ou,Charlotta Pisinger,P. Van Hove,Jeffrey S. Ross,Phil Stephens,Virginia L. Miller,Manish R. Patel	2016	2
20	Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells Investigational New Drugs ·Alfredo Revenaz,Blake A. Jacobson,Manish R. Patel,Xiaowen Wang,E F Vernon Thatcher,M. Piskorz,Sanaz Hadidchi,Peter B. Bitterman,Carston R. Wagner,Robert A. Kratzke	2014	22

About Manish R. Patel

Manish R. Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 94 papers that have together received 1.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (19 papers), Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (15 papers), Lung Cancer Research Studies (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Animal Virus Infections Studies (7 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Oncology (701 citations), Pathology and Forensic Medicine (286 citations) and Immunology (306 citations). Manish R. Patel has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Robert A. Kratzke, Blake A. Jacobson, Simcha Pollack, John F. Aloia, Mageda Mikhail, Melissa Li‐Ng, James K. Yeh, Sanjiv S. Gambhir, Yan Ji and Zhen Cheng. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Investigational New Drugs and Cancer Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact